UPEXI INC (UPXI) Fundamental Analysis & Valuation

NASDAQ:UPXI • US39959A2050

Current stock price

0.933 USD
-0.08 (-7.62%)
At close:
1.03 USD
+0.1 (+10.4%)
After Hours:

This UPXI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. UPXI Profitability Analysis

1.1 Basic Checks

  • In the past year UPXI has reported negative net income.
  • UPXI had a negative operating cash flow in the past year.
  • UPXI had negative earnings in 4 of the past 5 years.
  • In multiple years UPXI reported negative operating cash flow during the last 5 years.
UPXI Yearly Net Income VS EBIT VS OCF VS FCFUPXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of UPXI (-45.34%) is worse than 81.08% of its industry peers.
  • Looking at the Return On Equity, with a value of -252.35%, UPXI is doing worse than 78.38% of the companies in the same industry.
Industry RankSector Rank
ROA -45.34%
ROE -252.35%
ROIC N/A
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
UPXI Yearly ROA, ROE, ROICUPXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

  • UPXI has a Gross Margin of 80.67%. This is amongst the best in the industry. UPXI outperforms 97.30% of its industry peers.
  • UPXI's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for UPXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
UPXI Yearly Profit, Operating, Gross MarginsUPXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. UPXI Health Analysis

2.1 Basic Checks

  • UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • UPXI has more shares outstanding than it did 1 year ago.
  • UPXI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, UPXI has an improved debt to assets ratio.
UPXI Yearly Shares OutstandingUPXI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
UPXI Yearly Total Debt VS Total AssetsUPXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • UPXI has an Altman-Z score of -2.54. This is a bad value and indicates that UPXI is not financially healthy and even has some risk of bankruptcy.
  • UPXI's Altman-Z score of -2.54 is on the low side compared to the rest of the industry. UPXI is outperformed by 83.78% of its industry peers.
  • UPXI has a Debt/Equity ratio of 4.25. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 4.25, UPXI is not doing good in the industry: 78.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF N/A
Altman-Z -2.54
ROIC/WACCN/A
WACC7.93%
UPXI Yearly LT Debt VS Equity VS FCFUPXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.20 indicates that UPXI has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.20, UPXI perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
  • UPXI has a Quick Ratio of 2.19. This indicates that UPXI is financially healthy and has no problem in meeting its short term obligations.
  • UPXI's Quick ratio of 2.19 is fine compared to the rest of the industry. UPXI outperforms 72.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.19
UPXI Yearly Current Assets VS Current LiabilitesUPXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. UPXI Growth Analysis

3.1 Past

  • UPXI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.76%, which is quite impressive.
  • Looking at the last year, UPXI shows a very strong growth in Revenue. The Revenue has grown by 329.54%.
  • Measured over the past years, UPXI shows a quite strong growth in Revenue. The Revenue has been growing by 16.37% on average per year.
EPS 1Y (TTM)75.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.29%
Revenue 1Y (TTM)329.54%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%101.02%

3.2 Future

  • UPXI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.24% yearly.
  • Based on estimates for the next years, UPXI will show a very strong growth in Revenue. The Revenue will grow by 33.30% on average per year.
EPS Next Y-3.8%
EPS Next 2Y20.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year120.96%
Revenue Next 2Y33.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UPXI Yearly Revenue VS EstimatesUPXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
UPXI Yearly EPS VS EstimatesUPXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. UPXI Valuation Analysis

4.1 Price/Earnings Ratio

  • UPXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year UPXI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UPXI Price Earnings VS Forward Price EarningsUPXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UPXI Per share dataUPXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4 -5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as UPXI's earnings are expected to grow with 20.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.24%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UPXI Dividend Analysis

5.1 Amount

  • No dividends for UPXI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UPXI Fundamentals: All Metrics, Ratios and Statistics

UPEXI INC

NASDAQ:UPXI (4/7/2026, 9:08:56 PM)

After market: 1.03 +0.1 (+10.4%)

0.933

-0.08 (-7.62%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-10
Earnings (Next)05-12
Inst Owners26.81%
Inst Owner Change0%
Ins Owners8.09%
Ins Owner Change5.29%
Market Cap65.09M
Revenue(TTM)24.74M
Net Income(TTM)-122.93M
Analysts82.5
Price Target5.1 (446.62%)
Short Float %34.35%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)843.14%
Min EPS beat(2)-5664.71%
Max EPS beat(2)7350.98%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.63%
Min Revenue beat(2)-16.2%
Max Revenue beat(2)-1.06%
Revenue beat(4)1
Avg Revenue beat(4)-22.67%
Min Revenue beat(4)-82.88%
Max Revenue beat(4)9.44%
Revenue beat(8)1
Avg Revenue beat(8)-74.08%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-67.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1050%
EPS NY rev (1m)0%
EPS NY rev (3m)-3283.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.63
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.38
EV/EBITDA N/A
EPS(TTM)-5.29
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.35
BVpS0.7
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.34%
ROE -252.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.67%
FCFM N/A
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6558.83%
Cap/Sales 150.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.19
Altman-Z -2.54
F-Score5
WACC7.93%
ROIC/WACCN/A
Cap/Depr(3y)31.59%
Cap/Depr(5y)86.46%
Cap/Sales(3y)2.4%
Cap/Sales(5y)7.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.29%
EPS Next Y-3.8%
EPS Next 2Y20.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)329.54%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%101.02%
Revenue Next Year120.96%
Revenue Next 2Y33.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1409.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-677.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-205.66%
OCF growth 3YN/A
OCF growth 5YN/A

UPEXI INC / UPXI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UPEXI INC?

ChartMill assigns a fundamental rating of 3 / 10 to UPXI.


What is the valuation status of UPEXI INC (UPXI) stock?

ChartMill assigns a valuation rating of 1 / 10 to UPEXI INC (UPXI). This can be considered as Overvalued.


What is the profitability of UPXI stock?

UPEXI INC (UPXI) has a profitability rating of 2 / 10.


What is the earnings growth outlook for UPEXI INC?

The Earnings per Share (EPS) of UPEXI INC (UPXI) is expected to decline by -3.8% in the next year.